Home/Filings/4/0000905148-24-003412
4//SEC Filing

Zocca Mai-Britt 4

Accession 0000905148-24-003412

CIK 0001865494other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 6:56 PM ET

Size

5.6 KB

Accession

0000905148-24-003412

Insider Transaction Report

Form 4
Period: 2024-12-23
Zocca Mai-Britt
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2024-12-23$0.81/sh+12,500$10,12049,891 total
Holdings
  • Common Stock

    (indirect: Zocca Consulting ApS)
    26,580
Footnotes (2)
  • [F1]The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations.
  • [F2]The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of her pecuniary interest therein.

Documents

1 file

Issuer

IO Biotech, Inc.

CIK 0001865494

Entity typeother

Related Parties

1
  • filerCIK 0001890736

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:56 PM ET
Size
5.6 KB